🔎 Trials Near Me

Home › Interstitial Lung Diseases › Pennsylvania › Pittsburgh

Interstitial Lung Diseases clinical trials in Pittsburgh, PA

5 studies for Interstitial Lung Diseases are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

RecruitingPhase 3
  • University of Pittsburgh Medical Center, Pittsburgh
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07540988

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RecruitingPhase 2
  • UPMC Montefiore, Pittsburgh
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

RecruitingPhase 2/3
  • GSK Investigational Site, Pittsburgh
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

RecruitingObservational study
  • Michelle F MacPherson, Pittsburgh
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT00258583

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

RecruitingPhase 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Ages 8 to 60 · All sexes · Updated Aug 14, 2026 · NCT03630211

About Interstitial Lung Diseases

Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.

More about Interstitial Lung Diseases on MedlinePlus

Interstitial Lung Diseases trials in other cities

Other studies in Pittsburgh

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.